Skip to main content

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 95 / 1))

Abstract

Interleukin-6 (IL-6) is a multifunctional cytokine produced by both lymphoid and nonlymphoid cells (Kishimoto and Hirano 1988 a, b; Kishimoto 1988; Le and Vilcek 1989). IL-6 has previously been called by a variety of names, such as B-cell stimulatory factor 2 (BSF-2; Hirano et al. 1985), interferon-β2 (IFN-β2; Zilberstein et al. 1986), 26-kDa protein (Haegeman et al. 1986), hybridoma/plasmacytoma growth factor (Van Snick et al. 1986; Nordan and Potter 1986; Van Damme et al. 1987 a), and hepatocyte stimulating factor (HSF; Andus et al. 1987; Gauldie et al. 1987) on the basis of its biological activities. Following the molecular cloning of the cDNAs encoding BSF-2, IFN-β2, and 26-kDa protein (Hirano et al. 1986; Zilberstein et al. 1986; Haegeman et al. 1986), it was found that all these molecules were identical and therefore this molecule was called IL-6. It is now known that IL-6 is a polypeptide mediator regulating the immune response, the acute phase reaction, and hematopoiesis. Furthermore, it has been demonstrated that deregulated production of IL-6 is involved in a variety of chronic inflammatory diseases and certain lymphoid malignancies, especially plasmacytoma/myeloma. In fact, it was demonstrated that unregulated expression of the IL-6 gene in B-lineage cells causes development of a massive plasmacytosis histologically indistinguishable from plasmacytoma in transgenic mice with the immunoglobulin heavy chain enhancer—IL-6 gene (Suematsau et al. 1989).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aarden LP, Lansdorp, De Groot E (1985) A growth factor for B cell hybridomas produced by human monocytes. Lymphokines 10: 175–185

    CAS  Google Scholar 

  • Andus T, Geiger T, Hirano T, Northoff H, Ganter U, Bauer J, Kishimoto T, Heinrich PC (1987) Recombinant human B cell stimulatory factor 2 (BSF-2/IFNß 2) regulates ß-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett 221: 18–22

    Article  PubMed  CAS  Google Scholar 

  • Astaldi GCB, Janssen MC, Lansdorp PM, Willems C, Zeijlemaker WP, Oosterhof F (1980) Human endothelial culture supernatant (HECS): a growth factor for hybridomas. J Immunol 125: 1411–1414

    PubMed  CAS  Google Scholar 

  • Bowcock AM, Kidd JR, Lathrop M, Danshvar L, May LT, Ray A, Sehgal PB, Kidd KK, Cavallisforza LL (1988) The human “beta-2 interferon/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3: 8–16

    Article  PubMed  CAS  Google Scholar 

  • Brakenhoff JPJ, de Groot ER, Evers RF, Pannekoek H, Aarden LA (1987) Molecular cloning and expression of hybridoma growth factor in Escherichia coli J Immunol 139: 4116–4121

    CAS  Google Scholar 

  • Cancro M, Potter M (1976) The requirement of an adherent substratum for the growth of developing plasmacytoma cells in vivo. J Exp Med 144: 1554–1567

    Article  PubMed  CAS  Google Scholar 

  • Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC (1988a) Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232: 347350

    Google Scholar 

  • Castell JV, Geiger T, Gross V, Andus T, Walter E, Hirano T, Kishimoto T, Heinrich PC (1988b) Plasma clearance, organ distribution, and target cells of interleukin6/hepatocyte stimulating factor in the rat. Eur J Biochem 177: 357–361

    Article  PubMed  CAS  Google Scholar 

  • Chen L, Mory Y, Zilberstein A, Revel M (1988) Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant IFN-beta2 (BSF-2). Proc Natl Acad Sci USA 85: 8037–8041

    Article  PubMed  CAS  Google Scholar 

  • Chen Y, Ferguson-Smith AC, Newman MS, May LT, Sehgal PB, Ruddle FH (1987) Regional localization of the human B2-interferon gene. Am J Hum Genet 41: A161

    Google Scholar 

  • Content J, De Wit L, Pierard D, Derynck R, de Clercq E, Fiers W (1982) Secretory proteins induced in human fibroblasts under conditions used for the production of interferon ß. Proc Natl Acad Sci USA 79: 2768–2772

    Article  PubMed  CAS  Google Scholar 

  • Content J, De Wit L, Poupart P, Opdenakker G, Van Damme J, Billiau A (1985) Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1related, leukocyte-derived factor. Eur J Biochem 152: 253–257

    Article  PubMed  CAS  Google Scholar 

  • Corbel C, Melchers F (1984) The synergism of accessory cells and of soluble a-factors derived from them in the activation of B cells to proliferation Immunol Rev 78: 51–74

    CAS  Google Scholar 

  • Coulie PG, Vanhecke A, Van Damme J, Cayphas S, Poupart P, De Wit L, Content J (1987) High affinity sites for human 26-kDa protein (interleukin 6, B-cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type-1 interferon (alpha, beta) on lymphoblastoid cells. Eur J Immuno117: 1435–1440

    Google Scholar 

  • Dutton RW, Falkoff R, Hirst JA, Hoffman M, Kappler JW, Kattman JR, Lesley JF, Vann D (1971) Is there evidence for a nonantigen specific diffusable chemical mediator from the thymus cell in the initiation of the immune response? Prog Immunol 1: 355–368

    Google Scholar 

  • Frei K, Leist TP, Meager A, Gallo P, Leppert D, Zinkernagel RM, Fontana A (1988) Production of B cell stimulatory factor-2 and interferon y in the central nervous system during viral meningitis and encephalitis. J Exp Med 168: 449–453

    Article  PubMed  CAS  Google Scholar 

  • Garman RD, Jacobs KA, Clark SC, Raulet DH (1987) B-cell-stimulatory factor 2 (ß 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci USA 84: 7629–7633

    Article  PubMed  CAS  Google Scholar 

  • Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon ß 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocytestimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84: 7251–7255

    Article  PubMed  CAS  Google Scholar 

  • Gearing D, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, Metcalf D (1987) Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor ( LIF ). EMBO J 6: 3995–4002

    Google Scholar 

  • Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC (1988) Induc- tion of rat acute-phase proteins by interleukin-6 in vivo. Eur J Immunol 18: 717–721

    Article  PubMed  CAS  Google Scholar 

  • Haegeman G, Content J, Volckaert G, Derynck R, Tavernier J, Fiers W (1986) Structural analysis of the sequence encoding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem 159: 625–632

    Article  PubMed  CAS  Google Scholar 

  • Helfgott DC, May LT, Sthoeger Z, Tamm I, Sehgal PB (1987) Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of ß 2 interferon by human fibroblasts. J Exp Med 166: 1300–1309

    Article  PubMed  CAS  Google Scholar 

  • Helle M, Brakenhoff JPJ, De Groot ER, Aarden LA (1988) Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol 18: 957–959

    Article  PubMed  CAS  Google Scholar 

  • Hirano T, Teranishi T, Onoue K (1984a) Human helper T cell factor(s) III. Characterization of B cell differentiation factor I ( BCDFI ). J Immunol 132: 229–234

    Google Scholar 

  • Hirano T, Teranishi T, Lin BH, Onoue K (1984b) Human helper T cell factor(s) IV. Demonstration of a human late-acting B cell differentiation factor acting in Staphylococcus aureus Cowan I-stimulated B cells. J Immunol 133: 798–802

    PubMed  CAS  Google Scholar 

  • Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 82: 5490–5494

    Article  PubMed  CAS  Google Scholar 

  • Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73–76

    Article  PubMed  CAS  Google Scholar 

  • Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T (1987) Human B cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84: 228–231

    Article  PubMed  CAS  Google Scholar 

  • Hirano T, Matsuda T, Hosoi K, Okano A, Matsui H, Kishimoto T (1988 a) Absence of antiviral activity in recombinant B cell stimulatory factor 2 (BSF-2). Immunol Lett 17: 41–45

    Article  Google Scholar 

  • Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldman M, Kishimoto T (1988 b) Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797–1801

    Article  PubMed  CAS  Google Scholar 

  • Hodgkin PD, Bond MW, O’Garra A, Frank G, Lee F, Coffman RL, Zlotnik A, Howard M (1988) Identification of IL-6 as a T cell-derived factor that enhances the proliferative response of thymocytes to IL-4 and phorbol myristate acetate. J Immuno1141: 151–157

    Google Scholar 

  • Horii Y, Muraguchi A, Suematu S, Matsuda T, Yoshizaki K, Hirano T, Kishimoto T (1988) Regulation of BSF-2/IL-6 production by human mononuclear cells: macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 141: 1529–1535

    PubMed  CAS  Google Scholar 

  • Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y, Yoshizaki K, Hirano T, Kishimoto T (1989) Involvement of interleukin-6 in mesangial proliferative glomerulonephritis. J Immunol 143 (in press)

    Google Scholar 

  • Houssiau FA, Coulie PG, Olive D, Van Snick J (1988) Synergistic activation of human T cells by interleukin 1 and interleukin 6. Eur J Immunol 18: 653–656

    Article  PubMed  CAS  Google Scholar 

  • Ichikawa Y (1969) Differentiation of a cell line of myeloid leukemia. J Cell Physiol 74: 223–234

    Article  PubMed  CAS  Google Scholar 

  • Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M (1987) Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84: 9035–9039

    Article  PubMed  CAS  Google Scholar 

  • Ishibashi T, Kimura H, Uchida T, Karyone S, Friese P, Burstein SA (1989a) Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86: 5953–5957

    Article  PubMed  CAS  Google Scholar 

  • Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y (1989 b) Interleukin 6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241–1244

    Google Scholar 

  • Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83–85

    Article  PubMed  CAS  Google Scholar 

  • Kikutani H, Taga T, Akira S, Kishi H, Miki Y, Saiki O, Yamamura Y, Kishimoto T (1985) Effect of B cell differentiation factor ( BCDF) on biosynthesis and secretion of immunoglobulin molecules in human B cell lines. J Immunol 134: 990–995

    PubMed  CAS  Google Scholar 

  • Kishimoto T (1985) Factors affecting B cell growth and differentiation. Annu Rev Immunol 3: 133–159

    Article  PubMed  CAS  Google Scholar 

  • Kishimoto T (1988) B cell differentiation–interleukins and receptors for the antibody response. ISI Atlas of Science: Immunology 1: 149–154

    CAS  Google Scholar 

  • Kishimoto T, Hirano T (1988 a) Molecular regulation of B lymphocyte response. Annu Rev Immunol 6: 485–512

    Article  PubMed  CAS  Google Scholar 

  • Kishimoto T, Hirano T (1988 b) A new interleukin with pleiotropic activities. Bioessays 9: 11–15

    Article  PubMed  CAS  Google Scholar 

  • Kishimoto T, Ishizaka K (1973) Regulation of antibody responses in vitro. VII. Enhancing soluble factors for IgG and IgE antibody response. J Immunol 111: 1194–1205

    PubMed  CAS  Google Scholar 

  • Kohase M, May LT, Tamm I, Vilcek J, Sehgal PB (1987) A cytokine network in human diploid fibroblasts: interactions of ß-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol 7: 273–280

    PubMed  CAS  Google Scholar 

  • Koji A (1985) Definition and classification of acute-phase proteins. In: Gordon AH, Koji A (eds) The acute phase response to injury and infection. Elsevier, Amsterdam, p 139 (Research monographs in cell and tissue physiology, vol 10 )

    Google Scholar 

  • Koji A, Gauldie J, Regoeczi E, Sauder DN, Sweeney GD (1984) The acute-phase response of cultured rat hepatocytes. System characterization and the effect of human cytokines. Biochem J 224: 505–514

    Google Scholar 

  • Kushner I (1982) The phenomenon of the acute phase response. Ann NY Acad Sci 389: 39–48

    Article  PubMed  CAS  Google Scholar 

  • Le J, Vilcek J (1989) Interleukin 6. In: Barr PJ (ed) Growth factors and lymphokines: production and clinical application. Dekker, New York (in press)

    Google Scholar 

  • Le J, Fredrickson G, Reis LFL, Diamantsein T, Hirano T, Kishimoto T, Vilcek J (1988) Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc Natl Acad Sci USA 85: 8643–8647

    Article  PubMed  CAS  Google Scholar 

  • Lee F, Yokota T, Otsuka T, Meyerson P, Villaret D, Coffman R, Mosmann T, Rennick D, Roehm N, Smith C, Zlotnik A, Arai L (1986) Isolation and characterization of a mouse interleukin cDNA clone that expresses BSF-1 activities and T cell and mast cell stimulatory activities. Proc Natl Acad Sci USA 83: 2061–2065

    Article  PubMed  CAS  Google Scholar 

  • Lipton JH, Sachs L (1981) Characterization of macrophage-and granulocyte-inducing proteins for normal and leukemic myeloid cells produced by the Krebs ascites tumor. Biochim Biophys Acta 673: 552–569

    Article  PubMed  CAS  Google Scholar 

  • Lotz M, Jirik F, Kabouridis R, Tsoukas C, Hirano T, Kishimoto T, Carson DA (1988) BSF-2/IL-6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 167: 1253–1258

    Article  PubMed  CAS  Google Scholar 

  • Lovett DH, Ryan JL, Sterzel RB (1983) Stimulation of rat mesangial cell proliferation by macrophage interleukin 1. J Immuno1131: 2830–2836

    Google Scholar 

  • MacCarthy EP, Hsu A, Ooi BS (1985) Modulation of mouse mesangial cell proliferation by macrophage products. Immunology 56: 695–699

    PubMed  CAS  Google Scholar 

  • Matsuda T, Hirano T, Kishimoto T (1988) Establishment of a IL-6/BSF-2-dependent cell line and preparation of anti-IL-6/BSF-2 monoclonal antibodies. Eur J Immunol 18: 951–956

    Article  PubMed  CAS  Google Scholar 

  • Matsuda T, Hirano T, Nagasawa S, Kishimoto T (1989) Identification of a2-macroglobulin as a carrier protein for interleukin 6. J Immunol 142: 148–152

    PubMed  CAS  Google Scholar 

  • May LT, Helfgott DC, Sehgal PB (1986) Anti-ß-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the ß2-interferon involved. Proc Natl Acad Sci USA 83: 8957–8961

    Article  PubMed  CAS  Google Scholar 

  • Melcion C, Lachman L, Killen PD, Morel-Maroger L, Stricker GE (1982) Mesangial cells, effect of monocyte products on proliferation and matrix synthesis. Transplant Proc 14: 559–564

    PubMed  CAS  Google Scholar 

  • Metcalf D (1974) The serum factor stimulating colony formation in vitro by murine plasmacytoma cells: response to antigens and mineral oil. J Immunol 113: 235–243

    PubMed  CAS  Google Scholar 

  • Metcalf D (1986) The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 67: 257–267

    PubMed  CAS  Google Scholar 

  • Miyaura C, Onozaki K, Akiyama Y, Taniyama T, Hirano T, Kishimoto T, Suda T (1988) Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells ( M1 ). FEBS Lett 234: 17–21

    Google Scholar 

  • Mosmann TR, Coffman RL (1987) Two types of helper T-cell clone: implications for immune regulation. Immunol Today 8: 223–227

    Article  Google Scholar 

  • Muraguchi A, Kishimoto T, Miki Y, Kuratani T, Kaieda T, Yoshizaki K, Yamamura Y (1981) T cell-replacing factor ( TRF)-induced IgG secretion in human B blastoid cell line and demonstration of acceptors for TRF. J Immunol 127: 412–416

    Google Scholar 

  • Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T (1988) The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167: 332–344

    Article  PubMed  CAS  Google Scholar 

  • Mushinski JF, Bauer SR, Potter M, Reddy EP (1983) Increased expression of mycrelated oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane and Abelson murine leukemia virus. Proc Natl Acad Sci USA 80: 1073–1077

    Article  PubMed  CAS  Google Scholar 

  • Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda M, Nomura H, Ono M (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319: 415–418

    Article  PubMed  CAS  Google Scholar 

  • Nakajima K, Martinez-Maza O, Hirano T, Nishanian P, Salazar-Gonzalez JF, Fahey JL, Kishimoto T (1989) Induction of interleukin 6(BSF-2/IFN-ß 2) production by the human immunodeficiency virus ( HIV ). J Immunol 142: 144–147

    Google Scholar 

  • Namba Y, Hanaoka M (1972) Immunocytology of cultured IgM-forming cells of mouse. I. Requirement of phagocytic cell factor and its role in antibody formation. J Immunol 109: 1193–1200

    Google Scholar 

  • Nicola NA, Metcalf D, Matsumoto M, Johnson GR (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem 258: 9017–9023

    Google Scholar 

  • Nijstein MWN, De Groot ER, Ten Duis HJ, Klasen HJ, Hack CE, Aarden LA (1987) Serum levels of interleukin-6 and acute phase responses. Lancet ii: 921

    Google Scholar 

  • Noma T, Mizuta T, Rosen A, Hirano T, Kishimoto T, Honjo T (1987) Enhancement of the interleukin 2 receptor expression on T cells by multiple B-Iymphotropic lymphokines. Immunol Lett 15: 249–253

    Article  PubMed  CAS  Google Scholar 

  • Nordan RP, Potter M (1986) A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233: 566–569

    Article  PubMed  CAS  Google Scholar 

  • Nordan RP, Pumphrey JG, Rudikoff S (1987) Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immuno1139: 813–817

    Google Scholar 

  • Ohno S, Babonits M, Wiener F, Spira J, Klein G, Potter M (1979) Non-random chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristaneinduced mouse plasmacytomas. Cell 18: 1001–1007

    Article  PubMed  CAS  Google Scholar 

  • Okada M, Sakaguchi N, Yoshimura N, Hara H, Shimizu K, Yoshida N, Yoshizaki K, Kishimoto S, Yamamura Y, Kishimoto T (1983) B cell growth factor (BCGF) and B cell differentiation factor from human T hybridomas: two distinct kinds of BCGFs and their synergism in B cell proliferation. J Exp Med 157: 583–590

    Article  PubMed  CAS  Google Scholar 

  • Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T (1988) BSF2/IL-6 functions as killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 141: 1543–1549

    PubMed  CAS  Google Scholar 

  • Okano A, Suzuki C, Takatsuki F, Akiyama Y, Kake K, Ozawa K, Hirano T, Kishimoto T, Nakahata T, Asano S (1989) In vitro expansion of murine pluripotent hemopoietic stem cell population in response to interleukin 3 and interleukin 6: application to bone marrow transplantation. Transplantation 48: 495–498

    Article  PubMed  CAS  Google Scholar 

  • Potter M, Boyce C (1962) Induction of plasma cell neoplasms in strain Balb/c mice with mineral oil and mineral oil adjuvants. Nature 193: 1086–1087

    Article  PubMed  CAS  Google Scholar 

  • Poupart P, Vandenabeele P, Cayphas S, Snick JV, Haegeman G, Kruys V, Fiers W, Content J (1987) B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-ß 2, HPGF ). EMBO J 6: 1219–1224

    Google Scholar 

  • Prud’homme GJ, Fieser TM, Dixon FJ, Theofilopoulos AN (1984) B cell-tropic inter- leukins in murine systemic lupus erythematosus ( SLE ). Immunol Rev 78: 159–183

    Google Scholar 

  • Ray A, Tatter SB, May LT, Sehgal PB (1988) Activation of the human “ß 2interferon/hepatocyte-stimulating factor/interleukin 6” promoter by cytokines, viruses, and second messenger agonists. Proc Natl Acad Sci USA 85: 6701–6705

    Article  PubMed  CAS  Google Scholar 

  • Reis LL, Le J, Hirano T, Kishimoto T, Vilcek J (1988) Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-ß 2, and is inhibited by specific antibodies to IFN-ß. J Immunol 140: 1566–1570

    PubMed  CAS  Google Scholar 

  • Sachs L (1978) Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia. Nature 274: 535–539

    Article  PubMed  CAS  Google Scholar 

  • Sachs L (1987) The molecular control of blood cell development. Science 238: 1374–1379

    Article  PubMed  CAS  Google Scholar 

  • Sanderson CL, O’Garra A, Warren DJ, Klaus GGB (1986) Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. Proc Natl Acad Sci USA 83: 437–440

    Article  PubMed  CAS  Google Scholar 

  • Satoh T, Nakamura S, Taga T, Matsuda T, Hirano T, Kishimoto T, Kaziro Y (1988) Induction of neural differentiation in PC12 cells by B cell stimulatory factor 2/interleukin 6. Mol Cell Biol 8: 3546–3549

    PubMed  CAS  Google Scholar 

  • Schimpl A, Wecker E (1972) Replacement of T cell function by a T cell product. Nature 237: 15–17

    CAS  Google Scholar 

  • Sehgal PB, Zilberstein A, Ruggieri R-M, May LT, Ferguson-Smith A, Slate DL, Revel M, Ruddle F (1986) Human chromasome 7 carries the ß 2 interferon gene. Proc Natl Acad Sci USA 83: 5219–5222

    Article  PubMed  CAS  Google Scholar 

  • Sehgal PB, Walther Z, Tamm I (1987) Rapid enhancement of ß 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187. Proc Natl Acad Sci USA 84: 3633–3667

    Article  Google Scholar 

  • Sehgal PB, Helfgott DC, Santhanam U, Tatter SB, Clarick RH, Ghrayeb J, May LT (1988) Regulation of the acute phase and immune responses in viral disease. J Exp Med 167: 1951–1956

    Article  PubMed  CAS  Google Scholar 

  • Shabo Y, Lotem J, Rubinstein M, Revel M, Clark SC, Wolf SF, Kamen R, Sachs L (1988) The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin 6. Blood 72: 2070–2073

    PubMed  CAS  Google Scholar 

  • Shaw G, Kamen R (1986) A conserved AU sequence from the 3’ untranslated region of GM-CSF mRNA mediates selective degradation. Cell 46: 659–667

    Article  PubMed  CAS  Google Scholar 

  • Shimizu S, Hirano T, Yoshioka K, Sugai S, Matsuda T, Taga T, Kishimoto T, Konda S (1988) Interleukin 6 (B cell stimulatory factor 2)-dependent growth of a Lennert’s lymphoma-derived T cell line (KT-3). Blood 72: 1826–1828

    PubMed  CAS  Google Scholar 

  • Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, Grubin CE, Wignall JM, Jackson JL, Call SM, Friend D, Alpert AR, Gillis S, Urdal DL, Dower SK (1988) cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241: 585–589

    Google Scholar 

  • Sporn MB, Roberts AB (1988) Peptide growth factors are multifunctional. Nature 332:217–219 Striker GE, Striker LJ (1985) Biology of disease: glomerular cell culture. Lab Invest 53: 122–131

    Google Scholar 

  • Suematsu S, Matsuda T, Aozasa K, Akira S, Nakao N, Ohno S, Miyazaki J, Jamamura K, Hirano T, Kishimoto T (1989) IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 86: 7547–7551

    Article  PubMed  CAS  Google Scholar 

  • Sutton MGSJ, Mercier L, Giuliani ER, Lie JT (1980) Atrial myxomas: a review of clinical experience in 40 patients. Mayo Clin Proc 55: 371–376

    Google Scholar 

  • Taga T, Kawanishi K, Hardy RR, Hirano T, Kishimoto T (1987) Receptors for B cell stimulatory factor 2 (BSF-2): quantitation, specificity, distribution and regulation of the expression. J Exp Med 166: 967–981

    Article  PubMed  CAS  Google Scholar 

  • Taga T, Hibi M, Hirata Y, Yamasaki K, Yasakawa K, Matsuda T, Hirano T, Kishimoto T (1989) Interleukin-6 (IL-6) triggers the association of its receptor (IL-6-R) with a possible signal transducer, gp 130. Cell 58: 573–581

    Article  PubMed  CAS  Google Scholar 

  • Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH (1988) B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 140: 508–512

    PubMed  CAS  Google Scholar 

  • Takatsuki F, Okano A, Suzuki C, Chieda R, Takahara Y, Hirano T, Kishimoto T, Hamuro J, Akiyama Y (1988) Human recombinant interleukin 6/B cell stimulatory factor 2 (IL-6/BSF-2) augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol 141: 3072–3077

    PubMed  CAS  Google Scholar 

  • Tanabe O, Akira S, Kamiya T, Wong GG, Hirano T, Kishimoto T (1988) Genomic structure of the murine IL-6 gene: high degree conservation of potential regulatory sequences between mouse and human. J Immunol 141: 3875–3881

    PubMed  CAS  Google Scholar 

  • Teranishi T, Hirano T, Arima N, Onoue K (1982) Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor-(TRF) like factor(s). J Immunol 128: 1903–1908

    Google Scholar 

  • Teranishi T, Hirano T, Lin BH, Onoue K (1984) Demonstration of the involvement of interleukin 2 in the differentiation of Staphylococcus aureus Cowan I-stimulated B cells. J Immunol 133: 3062–3067

    PubMed  CAS  Google Scholar 

  • Theofilopoulos AN, Dixon FJ (1985) Murine models of systemic lupus erythematosus. Adv Immunol 37: 269–390

    Article  PubMed  CAS  Google Scholar 

  • Tomita M, Yamamoto-Yamaguchi Y, Hozumi M (1984) Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 259: 10978–10982

    Google Scholar 

  • Tomita M, Yamamoto-Yamaguchi Y, Hozumi M, Okabe T, Takaku F (1986) Induction by recombinant human granulocyte colony-stimulating factor of differentiation of mouse myeloid leukemic M1 cells. FEBS Lett 207: 271–275

    Article  Google Scholar 

  • Tosato G, Seamon KB, Goldman ND, Sehgal PB, May LT, Washington GC, Jones KD, Pike SE (1988) Monocyte-derived human B-cell growth factor identified as interferon-ß 2 (BSF-2, IL-6). Science 239: 502–504

    Article  PubMed  CAS  Google Scholar 

  • Tsuchiya M, Shigetaka A, Kaziro Y, Nagata S (1986) Isolation and characterization of the cDNA for murine granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 84: 7633–7637

    Article  Google Scholar 

  • Uyttenhove C, Coulie PG, Van Snick J (1988) T cell growth and differentiation induced by interleukin-Hpl/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med 167: 1417–1427

    Article  PubMed  CAS  Google Scholar 

  • Van Damme J, De Ley M, Opdenakker G, Billiau A, De Somer P (1985) Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature 314: 266–268

    Article  PubMed  Google Scholar 

  • Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billiau A, Snick JV (1987 a) Identification of the human 26-kD protein, interferon ß 2 (IFNß 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 165: 914–919

    Google Scholar 

  • Van Damme J, De Ley M, Van Snick J, Dinarello CA, Billiau A (1987b) The role of interferon-ß 1 and the 26-kDa protein (interferon-ß 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. J Immunol 139: 1867–1872

    PubMed  Google Scholar 

  • Van Damme J, Cayphas S, Opdenakker G, Billiau A, Van Snick J (1987 c) Interleukin 1 and poly(rI)•poly(rC) induce production of a hybridoma growth factor by human fibroblasts. Eur J Immunol 17: 1–7

    Google Scholar 

  • Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ (1986) Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83: 9679–9683

    Article  PubMed  Google Scholar 

  • Van Snick J, Vink A, Cayphas S, Uyttenhove C (1987) Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas. J Exp Med 165: 641–649

    Article  PubMed  Google Scholar 

  • Van Snick J, Cayphas S, Szikora J-P, Renauld J-C, Van Roost E, Boon T, Simpson RJ (1988) cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur J Immunol 18: 193–197

    Google Scholar 

  • Vink A, Coulie PG, Wauters P, Nordan RP, Van Snick J (1988) B cell growth and differentiation activity of interleukin-HP1 and related murine plasmacytoma growth factors. Synergy with interleukin 1. Eur J Immunol 18: 607–612

    Article  PubMed  CAS  Google Scholar 

  • Walther Z, May LT, Sehgal PB (1988) Transcriptional regulation of the interferon-ß 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines. J Immunol 140: 974–977

    PubMed  CAS  Google Scholar 

  • Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U, Wallach D, Perricaudet M, Tiollais P, Revel M (1980) Two interferon mRNA in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 77: 7152–7156

    Article  PubMed  CAS  Google Scholar 

  • Williams AF, Barclay AN (1988) The immunoglobulin superfamily–domains for cell surface recognition. Annu Rev Immunol 6: 381–405

    Article  PubMed  CAS  Google Scholar 

  • Woloski BM, Smith EM, Meyer WJ, Fuller GM (1985) Corticotropin-releasing activity of monokines. Science 230: 1035–1037

    Article  PubMed  CAS  Google Scholar 

  • Wong GHW, Goeddel DV (1986) Tumor necrosis factors a and ß inhibit virus replication and synergize with interferons. Nature 323: 819–822

    Article  PubMed  CAS  Google Scholar 

  • Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T (1988) Cloning and expression of the human interleukin-6 (BSF2/IFNß) receptor. Science 241: 825–828

    Article  PubMed  CAS  Google Scholar 

  • Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Kishimoto T (1987) Structure and expression of human B cell stimulatory factor 2 (BSF-2/IL-6) gene. EMBO J 6: 2939–2945

    PubMed  CAS  Google Scholar 

  • Yoshizaki K, Nakagawa T, Kaieda T, Muraguchi A, Yamamura Y, Kishimoto T (1982) Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol 128: 1296–1301

    PubMed  CAS  Google Scholar 

  • Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T, Kishimoto S, Hirano T, Kishimoto T (1989) Pathological significance of interleukin 6 (IL-6/BSF-2) in Castleman’s disease. Blood 74: 1360–1367

    PubMed  CAS  Google Scholar 

  • Zhang Y, Lin J-X, Vilcek J (1988 a) Synthesis of interleukin 6 (interferon-ß 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 263: 6177–6182

    PubMed  CAS  Google Scholar 

  • Zhang Y, Lin J-X, Yip YK, Vilcek J (1988 b) Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc Natl Acad Sci USA 85: 6802–6805

    Article  PubMed  CAS  Google Scholar 

  • Zilberstein A, Ruggieri R, Korn JH, Revel M (1986) Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J 5: 2529–2537

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hirano, T., Kishimoto, T. (1990). Interleukin-6. In: Sporn, M.B., Roberts, A.B. (eds) Peptide Growth Factors and Their Receptors I. Handbook of Experimental Pharmacology, vol 95 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-49295-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-49295-2_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-49297-6

  • Online ISBN: 978-3-642-49295-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics